ConductScience.org, home

Paper7397706

Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.

Ignoffo RJ and 1 other. Cancer Treat Rev, 1980. Cited by 111 papers, by iCite.

Cite this record

ConductScience Library. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Papers, record 7397706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7397706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.
PubMed
Journal
Cancer Treat Rev
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
111
iCite
Relative citation ratio, by iCite
6.14
iCite
Revised in PubMed
2019-10-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ignoffo RJR J
2Friedman MAM A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Animals
Antibiotics, Antineoplastic
Antidotes
Blister
Blood Vessels
Cell Membrane Permeability
DNA, Neoplasm
Humans
Inflammation
Injections
Necrosis
Neoplasms
Phlebitis
Radiotherapy
Risk

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.

PMIDTitleJournalYearIn PapersSource
39380955Radiopharmaceutical extravasations: a twenty year mini-review.Front Nucl Med2023https://conductscience.org/library/papers/39380955PubMed
28058065Extravasation emergencies: state-of-the-art management and progress in clinical research.Memo2016https://conductscience.org/library/papers/28058065PubMed
25711653Management of the extravasation of anti-neoplastic agents.Support Care Cancer2015https://conductscience.org/library/papers/25711653PubMed
25433440Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.Support Care Cancer2015https://conductscience.org/library/papers/25433440PubMed
23738141Extravasation injuries in adults.ISRN Dermatol2013https://conductscience.org/library/papers/23738141PubMed
21274082Practical cancer chemotherapy: venous access and extravasation.Can Fam Physician1985https://conductscience.org/library/papers/21274082PubMed
21263996Increasing the benefits of chemotherapy by ameliorating the adverse effects.Can Fam Physician1987https://conductscience.org/library/papers/21263996PubMed
21136240[Antineoplastic drug-induced extravasation].Med Klin (Munich)2010https://conductscience.org/library/papers/21136240PubMed
19888614[Prevention, early diagnosis and treatment of chemoextravasation. Practical management in the uro-oncological practice].Urologe A2009https://conductscience.org/library/papers/19888614PubMed
15237653[Extravasation of cytotoxic agents].Wien Klin Wochenschr2004https://conductscience.org/library/papers/15237653PubMed
12690542A review of clinical experience with paclitaxel extravasations.Support Care Cancer2003https://conductscience.org/library/papers/12690542PubMed
9085159Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: pilot study.J Gastroenterol1997https://conductscience.org/library/papers/9085159PubMed
7646823Prevention and management of extravasation of cytotoxic drugs.Drug Saf1995https://conductscience.org/library/papers/7646823PubMed
7295513Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis.Br J Cancer1981https://conductscience.org/library/papers/7295513PubMed
3995685Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3995685PubMed
3948308Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948308PubMed
3621451Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3621451PubMed
3313357Cancer chemotherapy agent-induced perivenous extravasation injuries.Postgrad Med J1987https://conductscience.org/library/papers/3313357PubMed
3121673Experimental chemotherapy-induced skin necrosis in swine. Mechanistic studies of anthracycline antibiotic toxicity and protection with a radical dimer compound.J Clin Invest1988https://conductscience.org/library/papers/3121673PubMed
2706738Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2706738PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7397706

GET https://conductscience.org/api/papers/v1/7397706/cited_by?page=2